Pharma Industry News

Cambridge spin-out PharmEnable raises £1.8m for drug discovery

The funds will enable in-house drug discovery across a number of therapeutic areas including cancer and neurodegenerationOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]